DEERFIELD, Ill., July 22 /PRNewswire/ -- Siemens Healthcare showcases new and innovative solutions that automate workflow in the clinical laboratory through system consolidation and inter-connectivity of systems in booth #415, Exhibit hall A, McCormick Center, at the 2009 American Association for Clinical Chemistry (AACC) Expo in Chicago, Illinois July 21-23, 2009. Educational workshops sponsored by Siemens and in-booth presentations will cover topics such as sepsis, allergy, women's heart health, and the financial crisis and healthcare reform.
Siemens will sponsor workshops highlighting the latest thought leadership on topics ranging from new tools to aid in the early identification and treatment of sepsis and the emerging trend of automated testing for infectious disease to the financial crisis and healthcare reform. Additional in-booth presentations will highlight how Siemens is helping address several of today's most critical healthcare issues, including the growing incidence of heart disease in women and recent advancements in the use of diagnostics to help improve the management of liver disease. Siemens will also share highlights from its latest research and development initiatives with over 30 scientific poster sessions during the Expo.
In addition, as part of the Siemens Disney alliance -- a twelve year strategic partnership based on Siemens commitment to the delivery of quality healthcare and Disney's legacy of caring for children -- the Siemens booth will feature a presentation on the important role 3gAllergy(TM) blood test plays in the early detection of allergies in children.
"We are excited to share our latest products and solutions with clinical laboratory customers," said Donal Quinn, CEO, Siemens Healthcare Diagnostics. "Our product designs result from collaborating with customers, staying focused on their needs and working together to take diagnostics to the next level."
The Siemens booth at this year's 2009 AACC will feature a number of Siemens newest instruments and assays, including:
Siemens will also feature the newest assays from their extensive test menu, including INNOVANCE((R)) D-Dimer, an aid in the diagnosis of deep vein thrombosis and INNOVANCE antithrombin tests an aid in the diagnosis of antithrombin deficiency and other coagulation disorders; Hemoglobin A1c to monitor patients with diabetes; CardioPhase((R)) hsCRP for cardiac risk assessment; Cystatin C for identifying kidney dysfunction; Berichrom Heparin calibrators and controls used with tests that monitor heparin levels; and new concentrated reagents that are diluted automatically on any ADVIA chemistry system on a per-test basis.
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy, and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs around 49,000 people worldwide and operates in 130 countries. In the fiscal year 2008 (Sept. 30), Siemens Healthcare reported sales of euro 11.2 billion, orders of euro 11.8 billion, and Sector profit of euro 1.2 billion. Further information can be found by visiting www.siemens.com/healthcare.
|SOURCE Siemens Healthcare|
Copyright©2009 PR Newswire.
All rights reserved